1 follower
Dyve is a clinical-stage biotech company with its lead asset, DYV700, currently completing a 20-center, 100-patient, Phase 2 clinical study for the treatment of acute gout.
Calico
6 followers
Neuron23
1 follower
Cardurion Pharmaceuticals
1 follower
Ultima Genomics
3 followers
Manifold Bio
2 followers
Thermo Fisher Scientific
166 followers
Genentech
150 followers
Illumina
67 followers
Agilent Technologies
63 followers
Charles River Laboratories
11 followers
Cytiva
10 followers
Explore companies